
    
      The purpose of the investigation is to confirm the followings under the post-marketing actual
      long-term use of FASENRA Subcutaneous Injection 30 mg Syringe.

        1. Detection of unexpected Adverse Drug Reactions

        2. To grasp development of Adverse Drug Reactions

        3. To grasp contributing factors possibly having an impact on the safety and efficacy

        4. Development of key investigational safety specification (serious infection).
    
  